Strategic Tech & Business Innovation

The Vermont ski maker's new certification signals a shift from carbon neutrality to verified climate action. Can performance and planet truly coexist?

Textron Aviation's massive contract extension ensures the T-6 Texan II trainer fleet remains mission-ready, securing the U.S. pilot pipeline for years.

Fresh off a massively oversubscribed IPO, Chinese robotics firm Huayan debuts at Hannover Messe, challenging industry giants with advanced AI and automation.

A major US mutual life insurer is launching a Bermuda reinsurer with Agam Capital's help, highlighting a trend of using tech to optimize capital offshore.

A new native integration between Cloudpager and Citrix Studio aims to end VDI image sprawl, modernize legacy apps, and slash disaster recovery times.

Ontario’s public broadcaster appoints a new growth VP, signaling a major push for self-generated revenue to secure its future in a complex media world.

The market for at-home NAD+ therapy is booming, but as telehealth offers new convenience, it faces a wave of regulatory and safety questions.

Investors watch Gibson Energy closely as it prepares for its Q1 results amid mixed performance, strategic acquisitions, and a changing energy landscape.

A new AI parenting app, Kung Fu Family, promises personalized advice. But as it learns your child, it raises big questions about privacy and tech's role in family life.

GCEI is shifting into the AI-driven climate tech market with a new acquisition and an initiative to predict wildfires and floods before they strike.

The premium Canadian cannabis leader is leveraging its domestic success for a strategic European expansion, targeting booming medical markets in Germany and the UK.

Amid record growth, the national ice cream giant targets Southern Louisiana for new stores, offering a sweet opportunity for local entrepreneurs.

China's Gan & Lee partners with JW Pharmaceutical to launch its novel bi-weekly GLP-1 drug, Bofanglutide, into the competitive South Korean market.

New Medicare billing codes for the biosimilar Tyenne are now in effect, simplifying reimbursement and aiming to improve access for severe COVID-19 patients.

AllRock Bio has begun a Phase 2a trial for its novel drug ROC-101, testing it in combination with new standard-of-care therapies for pulmonary hypertension.

Facing crippling compliance costs and advanced threats, small defense contractors get a new lifeline with Celerium's automated DIB CyberDome platform.

The power cooperative will discuss its 2025 financials as it navigates massive infrastructure projects and record energy demand from Georgia's growing economy.

Following positive safety data, Phanes Therapeutics expands trials for spevatamig, a first-in-class antibody targeting two cancer pathways at once.

Miami startup Petwealth emerges from stealth with at-home PCR tests and key partnerships, aiming to revolutionize the $200B pet health industry.

A landmark partnership aims to create unprecedented opportunities for Hispanic youth, blending corporate power with grassroots community and culture.